
Federal Government Relations
Viewpoint
Filter by:
As Walsh Awaits Confirmation Vote, DOL Priorities Take Shape
February 16, 2021| Blog
Last week, the Senate Committee on Health, Education, Labor, and Pensions voted 18-4 to advance Boston Mayor Marty Walsh’s nomination for labor secretary. The bipartisan approval signals a non-controversial confirmation vote of the full Senate. When that occurs, Secretary-designate Walsh will take over a department that is front and center in the nascent Biden administration. Executing White House priorities including the federal response to the COVID-19 pandemic, addressing the climate crisis, and reversing certain Trump era actions, will soon be Walsh’s responsibility. His experience in Massachusetts politics gives a sense of how Walsh will approach his new post.
Transportation & Infrastructure: What to Expect from the Biden Administration & 117th Congress
February 4, 2021| Blog
With Democratic majorities in the U.S. House and U.S. Senate, Congress and President Biden’s new administration are working to quickly advance proposals to provide for economic relief as the nation continues to reel from the now nearly one-year pandemic. One area of emerging bipartisan focus is a long-sought measure to address the nation’s crumbling and outdated infrastructure, which could be paired with a required surface transportation reauthorization bill.
Energy & Sustainability: What to Expect from the 117th Congress and the Biden Administration
January 15, 2021| Blog
After what felt like one of the longest election seasons in history, Washington is preparing to welcome the incoming administration of President-elect Joe Biden and Vice President-elect Kamala Harris. What does this all mean for energy and sustainability?
Action Items on Technology and Communication Policies in front of the Senate Commerce Committee
January 14, 2021| Blog
With the Senate set to flip to Democratic control in the 117th Congress, albeit by a razor thin margin, the policy priorities for the upper chamber are likely to significantly change. In so doing, the various Senate committees will have new chairs, and their agendas will likely vary at least in part on the partisan make-up of the committees.
ML Strategies Lame Duck Update: Trade and China Tariffs
December 8, 2020| Blog
Senate Passes IoT Cybersecurity Bill by Unanimous Consent
November 18, 2020| Blog
Massachusetts Congressional Delegation to the 117th Congress
November 10, 2020| Blog
Read about the Massachusetts congressional delegation to the 117th Congress, their current and potential committee assignments, and possible policy implications.
MLS Election Update: Impact on Trade
November 10, 2020| Blog
Read about the post-election impact on international trade matters and the incoming administration's influence on the Committee on Foreign Investments in the U.S. (CFIUS).
FDA Provides Update on Pre-Cert Program and Launches Digital Health Center of Excellence
October 19, 2020| Blog
Executive Compensation Practices in Pharma – Insight into Congressional Oversight
October 7, 2020| Blog
COVID-19 Government Relations
May 27, 2020| Blog
Next Steps for 21st Century Cures 2.0
May 7, 2020| Blog
What You Need to Know: State and Federal Updates Related to COVID-19
April 3, 2020| Blog
As the coronavirus pandemic spreads across the nation, your team at ML Strategies continues to monitor legislative and regulatory updates at the federal and state level. Each week, ML Strategies will provide weekly updates from Massachusetts and Washington, DC to keep you informed and aware of relief opportunities and guidance for your businesses and companies.
Collaborative Communities
February 27, 2020| Video
Aaron Josephson explains why FDA is looking to Collaborative Communities to help solve challenges in 2020 and the potential benefit to companies who participate in the development of public policy.
ML Strategies Health Care Preview: Surprise Billing Issue Heats Up
September 16, 2019| Blog
This week, Congress is working towards passage of a continuing resolution that would fund the government through the middle of November. This will give policymakers and appropriators enough time to hash out differences in funding priorities as well as work on policies addressing drug pricing, surprise billing, and funding for public health programs. The surprise billing issue is really heating up with outside stakeholder groups weighing in and Congress carefully considering its next steps
DHS’s Final EB-5 Regulations: What Stakeholders Need to Know
August 5, 2019| Alert
Read about DHS’s Final EB-5 Regulations that will take effect on November 21, 2019, including a new standard minimum investment amount of $1.8 million.
Senate Finance Committee Passes Drug Pricing Bill
July 30, 2019| Blog
Senators Chuck Grassley (R-IA) and Ron Wyden (D-OR), Chairman and Ranking Member (respectively) of the Senate Finance Committee, have fired the latest shot in Congress’s ongoing battle against high drug prices. Last week, the Senators introduced their much-anticipated proposal to lower drug prices: a chairman’s mark called the Prescription Drug Pricing Reduction Act (PDPRA) of 2019.
ML Strategies Health Care Preview: August Recess in Sight
July 29, 2019| Blog
This week, the Senate is expected to vote on a budget deal that would also suspend the debt limit for two years. This clears a major hurdle come September when both chambers of Congress will be in session with a laundry list of policies and programs to address, including appropriations.
Explore Other Viewpoints:
- Biden Administration
- Crisis Communications/Strategic Public Relations
- Disability & Special Populations
- Education
- Energy & Sustainability
- Federal Government Relations
- Financial Services
- Health Care
- Life Sciences & MedTech
- Real Estate & Project Development
- State & Local Government Relations
- Telecommunications & Technology
- Trade & International Affairs
- Transportation